发明名称 Methods of treating traveler's diarrhea and hepatic encephalopathy
摘要 Treatment of traveler's diarrhea using in subjects having hepatic encephalopathy using gastrointestinal specific antibiotics is disclosed. One example of a gastrointestinal specific antibiotic is rifaximin.
申请公布号 US8946252(B2) 申请公布日期 2015.02.03
申请号 US201213654978 申请日期 2012.10.18
申请人 Salix Pharmaceuticals, Ltd 发明人 Forbes William;Bortey Enoch
分类号 A61K31/437;A61P1/12 主分类号 A61K31/437
代理机构 McCarter & English, LLP 代理人 McCarter & English, LLP ;Sparks Jonathan M.;DeGrazia Michael J.
主权项 1. A method of reducing the risk of overt hepatic encephalopathy (HE) recurrence in a subject comprising: identifying a subject having Traveler's Diarrhea (TD) that also has hepatic insufficiency; determining if the subject's Child-Pugh score is Child-Pugh Class C or if the subject's model end stage liver disease (MELD) score is 25 or greater; and administering between 1000 and 1200 mg of rifaximin daily and cautiously to the subject if his or her Child-Pugh score is Child-Pugh Class C or if his or her MELD score is 25 or greater.
地址 Raleigh NC US